NCT06163469View on ClinicalTrials.gov

Effect of Chlorhexidine Gluconate Bladder Instillations in Patients With Chronic Suprapubic Catheters on Unplanned Healthcare Encounters and Quality of Life

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Neurogenic BladderUrinary Retention
Interventions
DEVICE

Bladder instillation with Irrisept

9 months of bladder instillations (3 months of saline and 6 months of chlorohexidine gluconate)

Trial Locations (1)

06519

RECRUITING

Yale New Haven Health, New Haven

Sponsors

Collaborators (1)

Irrimax Corporation
All Listed Sponsors
collaborator

Irrimax Corporation

INDUSTRY

lead

Yale University

OTHER

NCT06163469 - Effect of Chlorhexidine Gluconate Bladder Instillations in Patients With Chronic Suprapubic Catheters on Unplanned Healthcare Encounters and Quality of Life | Biotech Hunter | Biotech Hunter